Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

US Patent 11345752 · Granted May 31, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Engineered CD25 polypeptides and uses thereof2025
Antibodies binding to ILT42025
CD25 antibodies2025
CD19/CD38 multispecific antibodies2024
Anti-CD27 antibodies and uses thereof2024
Antibodies to TIGIT2024
Treatment of LAG-3 positive tumors2024
Treatment of LAG-3 positive tumors2023
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) 2023
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) 2023
Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an 2023